CCL2 and kidney disorder: To evaluate the repeatability of our findings in different renal disease conditions, we then planned to repeat the same steps of the study in a cohort of kidney transplant recipients, hypothesizing an influence of immunosuppressive therapy on patients’ MCP1 levels.